8 research outputs found
Non-invasion diagnostic methods β state of art and prospects of development
Π ΠΎΠ·Π³Π»ΡΠ½ΡΡΠΎ ΠΏΡΠΎΠ±Π»Π΅ΠΌΠΈ ΡΠΎΠ·Π²ΠΈΡΠΊΡ Π½Π΅ΡΠ½Π²Π°Π·ΠΈΠ²Π½ΠΈΡ
ΠΌΠ΅ΡΠΎΠ΄ΡΠ² Π΄ΡΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ. ΠΠ»Π°ΡΠΈΡΡΠΊΠΎΠ²Π°Π½ΠΎ Π³Π°Π»ΡΠ·Ρ Π½Π΅ΡΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΡ Π΄ΡΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ Π·Π° Π²ΠΈΠ΄Π°ΠΌΠΈ ΠΌΠ΅ΡΠΎΠ΄ΡΠ², ΡΠΎ Π²ΠΈΠΊΠΎΡΠΈΡΡΠΎΠ²ΡΡΡΡΡΡ, ΡΠΈΠΏΠ°ΠΌΠΈ Π·Π±ΠΈΡΠ°Π½ΠΈΡ
Π·ΡΠ°Π·ΠΊΡΠ². ΠΠ±Π³ΠΎΠ²ΠΎΡΠ΅Π½ΠΎ ΠΏΠ΅ΡΠ΅Π²Π°Π³ΠΈ ΡΠ° Π½Π΅Π΄ΠΎΠ»ΡΠΊΠΈ ΡΡΠ·Π½ΠΈΡ
ΠΌΠ΅ΡΠΎΠ΄ΡΠ² Π½Π΅ΡΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΡ Π΄ΡΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ. ΠΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½ΠΎ Π²Π½Π΅ΡΠΎΠΊ ΠΊΠ°ΡΠ΅Π΄ΡΠΈ Π±ΡΠΎΡΡΠ·ΠΈΠΊΠΈ ΡΠ° Π±ΡΠΎΡ
ΡΠΌΡΡ ΠΠ½ΡΠΏΡΠΎΠΏΠ΅ΡΡΠΎΠ²ΡΡΠΊΠΎΠ³ΠΎ Π½Π°ΡΡΠΎΠ½Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠ½ΡΠ²Π΅ΡΡΠΈΡΠ΅ΡΡ Ρ ΡΠΎΠ·Π²ΠΈΡΠΎΠΊ Π½Π΅ΡΠ½Π²Π°Π·ΠΈΠ²Π½ΠΈΡ
ΠΌΠ΅ΡΠΎΠ΄ΡΠ² Π΄ΡΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ Π±Π΅Π·ΠΏΠΎΡΠ΅ΡΠ΅Π΄Π½ΡΠΎ Ρ ΠΏΡΠ°ΠΊΡΠΈΡΠ½ΠΎΠΌΡ ΠΏΠ»Π°Π½Ρ.Π Π°ΡΡΠΌΠΎΡΡΠ΅Π½Ρ ΠΏΡΠΎΠ±Π»Π΅ΠΌΡ ΡΠ°Π·Π²ΠΈΡΠΈΡ Π½Π΅ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΡΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ. ΠΠ»Π°ΡΡΠΈΡΠΈΡΠΈΡΠΎΠ²Π°Π½Ρ ΠΎΡΡΠ°ΡΠ»Ρ Π½Π΅ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ ΠΏΠΎ Π²ΠΈΠ΄Π°ΠΌ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ², ΠΈΡΠΏΠΎΠ»ΡΠ·ΡΠ΅ΠΌΡΡ
ΡΠΈΠΏΠ°ΠΌΠΈ ΡΠΎΠ±ΠΈΡΠ°Π΅ΠΌΡΡ
ΠΎΠ±ΡΠ°Π·ΡΠΎΠ². ΠΠ±ΡΡΠΆΠ΄Π΅Π½Ρ ΠΏΡΠ΅ΠΈΠΌΡΡΠ΅ΡΡΠ²Π° ΠΈ Π½Π΅Π΄ΠΎΡΡΠ°ΡΠΊΠΈ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² Π½Π΅ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΠΎΠΉ Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ. ΠΡΠ΅Π΄ΡΡΠ°Π²Π»Π΅Π½Ρ Π²ΠΊΠ»Π°Π΄ ΠΊΠ°ΡΠ΅Π΄ΡΡ Π±ΠΈΠΎΡΠΈΠ·ΠΈΠΊΠΈ ΠΈ Π±ΠΈΠΎΡ
ΠΈΠΌΠΈΠΈ ΠΠ½Π΅ΠΏΡΠΎΠΏΠ΅ΡΡΠΎΠ²ΡΠΊΠΎΠ³ΠΎ Π½Π°ΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠ³ΠΎ ΡΠ½ΠΈΠ²Π΅ΡΡΠΈΡΠ΅ΡΠ° Π² ΡΠ°Π·Π²ΠΈΡΠΈΠ΅ Π½Π΅ΠΈΠ½Π²Π°Π·ΠΈΠ²Π½ΡΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ² Π΄ΠΈΠ°Π³Π½ΠΎΡΡΠΈΠΊΠΈ Π½Π΅ΠΏΠΎΡΡΠ΅Π΄ΡΡΠ²Π΅Π½Π½ΠΎ Π² ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΎΠΌ ΠΏΠ»Π°Π½Π΅.The progress of non-invasion diagnostic methods is under examination. Non-invasion diagnostic branch was classified according to using methods and obtained samples. The advantages and shortcomings of different non-invasion diagnostic methods were discussed. The contribution of Department of Biophysics and Biochemistry of Dnipropetrovsk National University into the progress of non-invasion technology was presented
Investigation of biochemical indices under gastric desorders
ΠΠΎΡΠ»ΡΠ΄ΠΆΠ΅Π½ΠΎ Π±ΡΠΎΡ
ΡΠΌΡΡΠ½Ρ ΠΏΠΎΠΊΠ°Π·Π½ΠΈΠΊΠΈ ΡΠΈΡΠΎΠ²Π°ΡΠΊΠΈ ΠΊΡΠΎΠ²Ρ Π»ΡΠ΄ΠΈΠ½ΠΈ: ΡΠΈΡΡΠ΅ΠΌΡ ΠΏΠ΅ΡΠ΅ΠΊΠΈΡΠ½ΠΎΠ³ΠΎ ΠΎΠΊΠΈΡΠ½Π΅Π½Π½Ρ, Π·Π°Π³Π°Π»ΡΠ½ΠΈΠΉ Π²ΠΌΡΡΡ Π»ΡΠΏΡΠ΄ΡΠ², Ρ
ΠΎΠ»Π΅ΡΡΠ΅ΡΠΎΠ»Ρ, Π»ΡΠΏΠΎΠΏΡΠΎΡΠ΅ΡΠ½ΡΠ² Π²ΠΈΡΠΎΠΊΠΎΡ ΡΡΠ»ΡΠ½ΠΎΡΡΡ, ΡΡΠΈΠ°ΡΠΈΠ»Π³Π»ΡΡΠ΅ΡΠΎΠ»ΡΠ² ΡΠ° ΡΠ΅ΡΡΠ»ΠΎΠΏΠ»Π°Π·ΠΌΡΠ½Ρ Π·Π° ΡΠΌΠΎΠ² Ρ
ΡΠΎΠ½ΡΡΠ½ΠΈΡ
Π½Π΅ΡΠΏΠ΅ΡΠΈΡΡΡΠ½ΠΈΡ
Π·Π°ΠΏΠ°Π»ΡΠ½ΠΈΡ
Π·Π°Ρ
Π²ΠΎΡΡΠ²Π°Π½Ρ ΠΊΠΈΡΠΎΠΊ. ΠΡΠΎΠ°Π½Π°Π»ΡΠ·ΠΎΠ²Π°Π½ΠΎ ΠΎΡΡΠΈΠΌΠ°Π½Ρ Π΄Π°Π½Ρ Π· Π±ΠΎΠΊΡ Π±ΡΠΎΡ
ΡΠΌΡΡΠ½ΠΈΡ
ΠΏΠΎΠΊΠ°Π·Π½ΠΈΠΊΡΠ² ΡΠ° ΡΠ°ΡΡΠΎΡΠΈ Π²ΡΠ΄Ρ
ΠΈΠ»Π΅Π½Ρ ΠΏΠΎΠΊΠ°Π·Π½ΠΈΠΊΡΠ² Ρ ΡΠΈΡΠΎΠ²Π°ΡΡΡ ΠΊΡΠΎΠ²Ρ Π²ΡΠ΄ Π½ΠΎΡΠΌΠΈ Ρ Ρ
Π²ΠΎΡΠΈΡ
Π½Π° Π²ΠΈΡΠ΅Π·Π°Π·Π½Π°ΡΠ΅Π½Ρ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΡΡ. ΠΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ Π½Π°ΡΠ²Π½ΡΡΡΡ Π±ΡΠΎΡ
ΡΠΌΡΡΠ½ΠΈΡ
Π·ΠΌΡΠ½ Ρ Ρ
Π²ΠΎΡΠΈΡ
Π½Π° Π·Π°ΠΏΠ°Π»ΡΠ½Ρ Π·Π°Ρ
Π²ΠΎΡΡΠ²Π°Π½Π½Ρ ΠΊΠΈΡΠΎΠΊ Π· Π±ΠΎΠΊΡ Π»ΡΠΏΡΠ΄Π½ΠΎΠ³ΠΎ ΠΎΠ±ΠΌΡΠ½Ρ ΡΠ° ΡΠΈΡΡΠ΅ΠΌΠΈ ΠΏΠ΅ΡΠ΅ΠΊΠΈΡΠ½ΠΎΠ³ΠΎ ΠΎΠΊΠΈΡΠ½Π΅Π½Π½Ρ, ΡΠΊΡ Π²ΡΠ΄ΡΠ³ΡΠ°ΡΡΡ Π³ΠΎΠ»ΠΎΠ²Π½Ρ ΡΠΎΠ»Ρ Ρ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ½ΠΈΡ
ΠΌΠ΅Ρ
Π°Π½ΡΠ·ΠΌΠ°Ρ
ΡΠΈΡ
Π·Π°Ρ
Π²ΠΎΡΡΠ²Π°Π½Ρ, ΠΌΠ°ΡΡΡ ΡΠ²ΠΎΡ ΠΊΠ»ΡΠ½ΡΡΠ½Ρ ΠΏΡΠΎΡΠ²ΠΈ ΡΠ° ΠΏΠΎΡΡΠ΅Π±ΡΡΡΡ ΡΠ΅ΡΠ°ΠΏΠ΅Π²ΡΠΈΡΠ½ΠΎΡ ΠΊΠΎΡΠ΅ΠΊΡΡΡ.ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Ρ Π±ΠΈΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»ΠΈ ΡΡΠ²ΠΎΡΠΎΡΠΊΠΈ ΠΊΡΠΎΠ²ΠΈ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ°: ΡΠΈΡΡΠ΅ΠΌΡ ΠΏΠ΅ΡΠ΅ΠΊΠΈΡΠ½ΠΎΠ³ΠΎ ΠΎΠΊΠΈΡΠ»Π΅Π½ΠΈΡ, ΠΎΠ±ΡΠ΅Π΅ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ Π»ΠΈΠΏΠΈΠ΄ΠΎΠ², Ρ
ΠΎΠ»Π΅ΡΡΠ΅ΡΠΎΠ»Π°, Π»ΠΈΠΏΠΎΠΏΡΠΎΡΠ΅ΠΈΠ½ΠΎΠ² Π²ΡΡΠΎΠΊΠΎΠΉ ΠΏΠ»ΠΎΡΠ½ΠΎΡΡΠΈ, ΡΡΠΈΠ°ΡΠΈΠ»Π³Π»ΠΈΡΠ΅ΡΠΎΠ»ΠΎΠ² ΠΈ Π¦Π΅ΡΡΠ»Π΅ΠΉ-ΠΏΠ»Π°Π·ΠΌΠΈΠ½Π° Π² ΡΡΠ»ΠΎΠ²ΠΈΡΡ
Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
Π½Π΅ΡΠΏΠ΅ΡΠΈΡΠΈΡΠ΅ΡΠΊΠΈΡ
Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ ΠΊΠΈΡΠ΅ΡΠ½ΠΈΠΊΠ°. ΠΡΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Ρ ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΡΠ΅ Π΄Π°Π½Π½ΡΠ΅ ΡΠΎ ΡΡΠΎΡΠΎΠ½Ρ Π±ΠΈΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ ΠΈ ΡΠ°ΡΡΠΎΡΡ ΠΎΡΠΊΠ»ΠΎΠ½Π΅Π½ΠΈΠΉ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Π΅ΠΉ Π² ΡΡΠ²ΠΎΡΠΎΡΠΊΠ΅ ΠΊΡΠΎΠ²ΠΈ ΠΎΡ Π½ΠΎΡΠΌΡ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Π²ΡΡΠ΅ΡΠΏΠΎΠΌΡΠ½ΡΡΡΠ΅ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΈ. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ Π½Π°Π»ΠΈΡΠΈΠ΅ Π±ΠΈΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠΉ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΠΌΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΠΌΠΈ ΠΊΠΈΡΠ΅ΡΠ½ΠΈΠΊΠ° ΡΠΎ ΡΡΠΎΡΠΎΠ½Ρ Π»ΠΈΠΏΠΈΠ΄Π½ΠΎΠ³ΠΎ ΠΎΠ±ΠΌΠ΅Π½Π° ΠΈ ΡΠΈΡΡΠ΅ΠΌΡ ΠΏΠ΅ΡΠ΅ΠΊΠΈΡΠ½ΠΎΠ³ΠΎ ΠΎΠΊΠΈΡΠ»Π΅Π½ΠΈΡ, ΠΊΠΎΡΠΎΡΡΠ΅ ΠΈΠ³ΡΠ°ΡΡ Π³Π»Π°Π²Π½ΡΡ ΡΠΎΠ»Ρ Π² ΠΏΠ°ΡΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠ°Ρ
ΡΡΠΈΡ
Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ, ΠΈΠΌΠ΅ΡΡ ΡΠ²ΠΎΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΠΏΡΠΎΡΠ²Π»Π΅Π½ΠΈΡ ΠΈ ΡΡΠ΅Π±ΡΡΡ ΡΠ΅ΡΠ°ΠΏΠ΅Π²ΡΠΈΡΠ΅ΡΠΊΠΎΠΉ ΠΊΠΎΡΡΠ΅ΠΊΡΠΈΠΈThe peroxidation system, general lipids, cholesterol, triglycerides, ceruloplasmin contents were examined under chronic non-specific inflammatory intestine diseases. The biochemical indices and deflexion frequency of pathological serum were analised. The biochemical changes were established in the blood serum of patients under chronic non-specific inflammatory intestine diseases. These changes play the most important role in the pathogenetic mechanisms, have their own clinical manifestations and demand the therapeutical correction
ΠΠ°ΠΊΠΎΠ½ΠΎΠΌΡΡΠ½ΠΎΡΡΡ Π²Π·Π°ΡΠΌΠΎΠ΄ΡΡ Π°Π½ΡΠΈΠ³Π΅Π½βΠ°Π½ΡΠΈΡΡΠ»ΠΎ Ρ ΡΠΎΠ·ΡΠΈΠ½Π°Ρ ΠΊΠ»Π°ΡΡΠ΅ΡΠ½ΠΈΡ ΡΠΏΠΎΠ»ΡΠΊ ΡΠ΅Π½ΡΡ ΡΠ° ΡΠΈΡΠΏΠ»Π°ΡΠΈΠ½Ρ
Influence of rhenium cluster compounds with different ligands on the antigen-antibody reactions by immunodiffusial and immunoelectrophoretical methods was studied. The different characters of influence of these agents on the immunochemical interactions are shown. Some common features of the rhenium compounds influence on the reactions with human immunoglobulins and antibodies are discussed.ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΎ Π²Π»ΠΈΡΠ½ΠΈΠ΅ ΠΊΠ»Π°ΡΡΠ΅ΡΠ½ΡΡ
ΡΠΎΠ΅Π΄ΠΈΠ½Π΅Π½ΠΈΠΉ ΡΠ΅Π½ΠΈΡ Ρ ΡΠ°Π·Π»ΠΈΡΠ½ΡΠΌΠΈ Π»ΠΈΠ³Π°Π½Π΄Π°ΠΌΠΈ Π½Π° ΡΠ΅Π°ΠΊΡΠΈΡ Π°Π½ΡΠΈΠ³Π΅Π½βΠ°Π½ΡΠΈΡΠ΅Π»ΠΎ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΈΠΌΠΌΡΠ½ΠΎΠ΄ΠΈΡΡΡΠ·ΠΈΠΎΠ½Π½ΡΡ
ΠΈ ΠΈΠΌΠΌΡΠ½ΠΎΡΠ»Π΅ΠΊΡΡΠΎΡΠΎΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΌΠ΅ΡΠΎΠ΄ΠΎΠ². ΠΠΎΠΊΠ°Π·Π°Π½ ΠΏΡΠΈΠ½ΡΠΈΠΏΠΈΠ°Π»ΡΠ½ΠΎ ΡΠ°Π·Π½ΡΠΉ Ρ
Π°ΡΠ°ΠΊΡΠ΅Ρ ΠΈΡ
Π²Π»ΠΈΡΠ½ΠΈΡ Π½Π° ΠΈΠΌΠΌΡΠ½ΠΎΡ
ΠΈΠΌΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π²Π·Π°ΠΈΠΌΠΎΠ΄Π΅ΠΉΡΡΠ²ΠΈΡ. ΠΡΠΎΠ°Π½Π°Π»ΠΈΠ·ΠΈΡΠΎΠ²Π°Π½Ρ Π·Π°ΠΊΠΎΠ½ΠΎΠΌΠ΅ΡΠ½ΠΎΡΡΠΈ Π²Π»ΠΈΡΠ½ΠΈΡ Π΄Π°Π½Π½ΡΡ
Π°Π³Π΅Π½ΡΠΎΠ² Π½Π° ΡΠ΅Π°ΠΊΡΠΈΡ ΠΌΠ΅ΠΆΠ΄Ρ ΠΈΠΌΠΌΡΠ½ΠΎΠ³Π»ΠΎΠ±ΡΠ»ΠΈΠ½Π°ΠΌΠΈ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ° ΠΈ Π°Π½ΡΠΈΡΠ΅Π»Π°ΠΌΠΈ ΠΏΡΠΎΡΠΈΠ² Π½ΠΈΡ
.ΠΠΎΡΠ»ΡΠ΄ΠΆΠ΅Π½ΠΎ Π²ΠΏΠ»ΠΈΠ² ΠΊΠ»Π°ΡΡΠ΅ΡΠ½ΠΈΡ
ΡΠΏΠΎΠ»ΡΠΊ ΡΠ΅Π½ΡΡ Π· ΡΡΠ·Π½ΠΎΠΌΠ°Π½ΡΡΠ½ΠΈΠΌΠΈ Π»ΡΠ³Π°Π½Π΄Π°ΠΌΠΈ Π½Π° ΡΠ΅Π°ΠΊΡΡΡ Π°Π½ΡΠΈΠ³Π΅Π½βΠ°Π½ΡΠΈΡΡΠ»ΠΎ Π· Π²ΠΈΠΊΠΎΡΠΈΡΡΠ°Π½Π½ΡΠΌ ΡΠΌΡΠ½ΠΎΠ΄ΠΈΡΡΠ·ΡΠΉΠ½ΠΈΡ
ΡΠ° ΡΠΌΡΠ½ΠΎΠ΅Π»Π΅ΠΊΡΡΠΎΡΠΎΡΠ΅ΡΠΈΡΠ½ΠΈΡ
ΠΌΠ΅ΡΠΎΠ΄ΡΠ². ΠΠΎΠΊΠ°Π·Π°Π½ΠΎ ΠΏΡΠΈΠ½ΡΠΈΠΏΠΎΠ²ΠΎ ΡΡΠ·Π½ΠΈΠΉ Ρ
Π°ΡΠ°ΠΊΡΠ΅Ρ Π²ΠΏΠ»ΠΈΠ²Ρ Π·Π°Π·Π½Π°ΡΠ΅Π½ΠΈΡ
Π°Π³Π΅Π½ΡΡΠ² Π½Π° ΡΠΌΡΠ½ΠΎΡ
ΡΠΌΡΡΠ½Ρ Π²Π·Π°ΡΠΌΠΎΠ΄ΡΡ. ΠΡΠΎΠ°Π½Π°Π»ΡΠ·ΠΎΠ²Π°Π½ΠΎ Π·Π°ΠΊΠΎΠ½ΠΎΠΌΡΡΠ½ΠΎΡΡΡ Π²ΠΏΠ»ΠΈΠ²Ρ Π΄Π°Π½ΠΈΡ
Π°Π³Π΅Π½ΡΡΠ² Π½Π° ΡΠ΅Π°ΠΊΡΡΡ ΠΌΡΠΆ ΡΠΌΡΠ½ΠΎΠ³Π»ΠΎΠ±ΡΠ»ΡΠ½Π°ΠΌΠΈ Π»ΡΠ΄ΠΈΠ½ΠΈ ΡΠ° Π°Π½ΡΠΈΡΡΠ»Π°ΠΌΠΈ Π΄ΠΎ Π½ΠΈΡ
.
ΠΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π½ΡΡ Π±Π΅Π»ΠΊΠΎΠ² ΡΡΠΈΡΡΠΎΡΠΈΡΠΎΠ² ΠΏΡΠΈ Π±Π΅ΡΠΊΠ°ΠΌΠ΅Π½Π½ΠΎΠΌ Ρ ΠΎΠ»Π΅ΡΠΈΡΡΠΈ-ΡΠ΅ ΠΈ Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΊΡΠΎΠ½Π°
The aim of the investigation was to reveal the changes in erythrocytesβ proteins from human blood under gastroenterological pathologies, namely noncalculous cholecystitis and Crohnβs disease. TheΒ erythrocyte was used as a model system. The PAAG electrophoresis with SDSNa method was used. Erythrocyte membrane proteins quantitative changes were observed in patient groups under liver and intestines diseases. High molecular weight proteins content (spectrines Ξ± and Ξ²) was reduced, but any changes were not registered under the Crohnβs disease. Low molecular weight proteins content (anion-transporting protein and protein band 4.5) increased considerably as compared with a control (healthy people group). TheΒ structure of erythrocytesβ membrane changed, that led to disturbance of function of cytoskeleton proteins. The research results give more wide explanations of the pathologies genesis.Β ΠΠΈΡΠ²Π»Π΅Π½ΠΎ Π·ΠΌΡΠ½ΠΈ Π±ΡΠ»ΠΊΡΠ² Π΅ΡΠΈΡΡΠΎΡΠΈΡΡΠ² ΠΊΡΠΎΠ²Ρ Π»ΡΠ΄ΠΈΠ½ΠΈ ΠΏΡΠΈ Π³Π°ΡΡΡΠΎΠ΅Π½ΡΠ΅ΡΠΎΠ»ΠΎΠ³ΡΡΠ½ΠΈΡ
ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΡΡΡ
(Π±Π΅Π·ΠΊΠ°ΠΌβΡΠ½ΠΎΠΌΡ Ρ
ΠΎΠ»Π΅ΡΠΈΡΡΠΈΡΡ ΡΠ° Ρ
Π²ΠΎΡΠΎΠ±Ρ ΠΡΠΎΠ½Π°). Π―ΠΊ ΠΌΠΎΠ΄Π΅Π»Ρ Π²Π·ΡΡΠΎ Π΅ΡΠΈΡΡΠΎΡΠΈΡ. ΠΠΌΡΠ½ΠΈ Π±ΡΠ»ΠΊΡΠ² Π΅ΡΠΈΡΡΠΎΡΠΈΡΡΠ² Ρ ΠΏΠ°ΡΡΡΠ½ΡΡΠ² ΡΠ· Π΄Π°Π½ΠΈΠΌΠΈ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΡΡΠΌΠΈ Π²ΠΈΠ²ΡΠ΅Π½ΠΎ Π·Π° Π΄ΠΎΠΏΠΎΠΌΠΎΠ³ΠΎΡ Π΅Π»Π΅ΠΊΡΡΠΎΡΠΎΡΠ΅ΡΠΈΡΠ½ΠΎΠ³ΠΎ ΠΌΠ΅ΡΠΎΠ΄Ρ Π² ΠΏΠΎΠ»ΡΠ°ΠΊΡΠΈΠ»Π°ΠΌΡΠ΄Π½ΠΎΠΌΡ Π³Π΅Π»Ρ Π·Π° ΠΏΡΠΈΡΡΡΠ½ΠΎΡΡΡ Π΄ΠΎΠ΄Π΅ΡΠΈΠ»ΡΡΠ»ΡΡΠ°ΡΡ Π½Π°ΡΡΡΡ. ΠΡΠΈ Π·Π°Ρ
Π²ΠΎΡΡΠ²Π°Π½Π½ΡΡ
ΠΏΠ΅ΡΡΠ½ΠΊΠΈ (Π±Π΅Π·ΠΊΠ°ΠΌβΡΠ½ΠΈΠΉ Ρ
ΠΎΠ»Π΅ΡΠΈΡΡΠΈΡ) Ρ Ρ
Π²ΠΎΡΠΎΠ±Π°Ρ
ΡΠΎΠ½ΠΊΠΎΠ³ΠΎ ΠΊΠΈΡΠΊΠΎΠ²ΠΈΠΊΠ° (Ρ
Π²ΠΎΡΠΎΠ±Π° ΠΡΠΎΠ½Π°) Ρ Π³ΡΡΠΏΠ°Ρ
ΠΏΠ°ΡΡΡΠ½ΡΡΠ² Π²ΡΠ΄Π±ΡΠ²Π°ΡΡΡΡΡ ΠΊΡΠ»ΡΠΊΡΡΠ½Ρ Π·ΠΌΡΠ½ΠΈ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π½ΠΈΡ
Π±ΡΠ»ΠΊΡΠ² Π΅ΡΠΈΡΡΠΎΡΠΈΡΡΠ². ΠΡΠΈ ΡΡΠΎΠΌΡ Π²ΠΌΡΡΡ Π²ΠΈΡΠΎΠΊΠΎΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΈΡ
Π±ΡΠ»ΠΊΡΠ² (ΡΠΏΠ΅ΠΊΡΡΠΈΠ½ΠΈ Ξ± ΡΠ° Ξ²) Π·Π½ΠΈΠΆΡΡΡΡΡΡ, Π° ΠΏΡΠΈ Ρ
Π²ΠΎΡΠΎΠ±Ρ ΠΡΠΎΠ½Π° Π·ΠΌΡΠ½ΠΈ Π½Π΅ ΡΠ΅ΡΡΡΡΡΡΡΡΡΡ. ΠΠΌΡΡΡ Π½ΠΈΠ·ΡΠΊΠΎΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΈΡ
Π±ΡΠ»ΠΊΡΠ² (Π°Π½ΡΠΎΠ½ΡΡΠ°Π½ΡΠΏΠΎΡΡΠ½ΠΈΠΉ Π±ΡΠ»ΠΎΠΊ Ρ Π±ΡΠ»ΠΎΠΊ ΡΠΌΡΠ³ΠΈ 4.5) Π·Π½Π°ΡΠ½ΠΎ ΠΏΡΠ΄Π²ΠΈΡΠ΅Π½ΠΈΠΉ ΠΏΠΎΡΡΠ²Π½ΡΠ½ΠΎ Π· ΠΊΠΎΠ½ΡΡΠΎΠ»Π΅ΠΌ (Π³ΡΡΠΏΠ° ΠΏΡΠ°ΠΊΡΠΈΡΠ½ΠΎ Π·Π΄ΠΎΡΠΎΠ²ΠΈΡ
Π»ΡΠ΄Π΅ΠΉ). ΠΠΈΡΠ²Π»Π΅Π½ΠΎ Π·ΠΌΡΠ½ΠΈ Ρ ΡΡΡΡΠΊΡΡΡΡ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½ Π΅ΡΠΈΡΡΠΎΡΠΈΡΡΠ², ΡΠΎ ΠΏΡΠΈΠ·Π²ΠΎΠ΄ΡΡΡ Π΄ΠΎ ΠΏΠΎΡΡΡΠ΅Π½Π½Ρ ΡΡΠ½ΠΊΡΡΠΉ Π±ΡΠ»ΠΊΡΠ² ΡΠΈΡΠΎΡΠΊΠ΅Π»Π΅ΡΠ°. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΠΈ Π΄ΠΎΡΠ»ΡΠ΄ΠΆΠ΅Π½Π½Ρ Π΄ΠΎΠΊΠ»Π°Π΄Π½ΡΡΠ΅ ΠΏΠΎΡΡΠ½ΡΡΡΡ ΠΏΡΠΈΡΠΈΠ½ΠΈ Π²ΠΈΠ½ΠΈΠΊΠ½Π΅Π½Π½Ρ ΡΠΈΡ
ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΡΠΉ.Β ΠΡΡΠ²Π»Π΅Π½Ρ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ Π±Π΅Π»ΠΊΠΎΠ² ΡΡΠΈΡΡΠΎΡΠΈΡΠΎΠ² ΠΊΡΠΎΠ²ΠΈ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ° ΠΏΡΠΈ Π³Π°ΡΡΡΠΎΡΠ½ΡΠ΅ΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΡ
(ΠΏΡΠΈ Π±Π΅ΡΠΊΠ°ΠΌΠ΅Π½Π½ΠΎΠΌ Ρ
ΠΎΠ»Π΅ΡΠΈΡΡΠΈΡΠ΅ ΠΈ Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΡΠΎΠ½Π°). Π ΠΊΠ°ΡΠ΅ΡΡΠ²Π΅ ΠΌΠΎΠ΄Π΅Π»ΠΈ Π²Π·ΡΡ ΡΡΠΈΡΡΠΎΡΠΈΡ. ΠΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΡ Π±Π΅Π»ΠΊΠΎΠ² ΡΡΠΈΡΡΠΎΡΠΈΡΠΎΠ² Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² Ρ Π΄Π°Π½Π½ΡΠΌΠΈ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡΠΌΠΈ ΠΈΠ·ΡΡΠ΅Π½ΠΎ Ρ ΠΏΠΎΠΌΠΎΡΡΡ ΡΠ»Π΅ΠΊΡΡΠΎΡΠΎΡΠ΅ΡΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΠΌΠ΅ΡΠΎΠ΄Π° Π² ΠΏΠΎΠ»ΠΈΠ°ΠΊΡΠΈΠ»Π°ΠΌΠΈΠ΄Π½ΠΎΠΌ Π³Π΅Π»Π΅ Π² ΠΏΡΠΈΡΡΡΡΡΠ²ΠΈΠΈ Π΄ΠΎΠ΄Π΅ΡΠΈΠ»ΡΡΠ»ΡΡΠ°ΡΠ° Π½Π°ΡΡΠΈΡ. ΠΡΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΡ
ΠΏΠ΅ΡΠ΅Π½ΠΈ (Π±Π΅ΡΠΊΠ°ΠΌΠ΅Π½Π½ΡΠΉ Ρ
ΠΎΠ»Π΅ΡΠΈΡΡΠΈΡ) ΠΈ Π±ΠΎΠ»Π΅Π·Π½ΡΡ
ΡΠΎΠ½ΠΊΠΎΠ³ΠΎ ΠΊΠΈΡΠ΅ΡΠ½ΠΈΠΊΠ° (Π±ΠΎΠ»Π΅Π·Π½Ρ ΠΡΠΎΠ½Π°) Π² Π³ΡΡΠΏΠΏΠ°Ρ
ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΏΡΠΎΠΈΡΡ
ΠΎΠ΄ΠΈΠ»ΠΈ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΠ΅ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½Π½ΡΡ
Π±Π΅Π»ΠΊΠΎΠ² ΡΡΠΈΡΡΠΎΡΠΈΡΠΎΠ². ΠΡΠΈ ΡΡΠΎΠΌ ΡΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ Π²ΡΡΠΎΠΊΠΎΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΡ
Π±Π΅Π»ΠΊΠΎΠ² (ΡΠΏΠ΅ΠΊΡΡΠΈΠ½Ρ Ξ± ΠΈ Ξ²) ΡΠ½ΠΈΠΆΠ°Π»ΠΎΡΡ, Π° ΠΏΡΠΈ Π±ΠΎΠ»Π΅Π·Π½ΠΈ ΠΡΠΎΠ½Π° ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ ΠΎΡΡΡΡΡΡΠ²ΠΎΠ²Π°Π»ΠΈ. Π‘ΠΎΠ΄Π΅ΡΠΆΠ°Π½ΠΈΠ΅ Π½ΠΈΠ·ΠΊΠΎΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΡΡ
Π±Π΅Π»ΠΊΠΎΠ² (Π°Π½ΠΈΠΎΠ½ΡΡΠ°Π½ΡΠΏΠΎΡΡΠ½ΡΠΉ Π±Π΅Π»ΠΎΠΊ ΠΈ Π±Π΅Π»ΠΎΠΊ ΠΏΠΎΠ»ΠΎΡΡ 4.5) Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎ ΠΏΠΎΠ²ΡΡΠ°Π»ΠΎΡΡ ΠΏΠΎ ΡΡΠ°Π²Π½Π΅Π½ΠΈΡ Ρ ΠΊΠΎΠ½ΡΡΠΎΠ»Π΅ΠΌ (Π³ΡΡΠΏΠΏΠ° ΠΏΡΠ°ΠΊΡΠΈΡΠ΅ΡΠΊΠΈ Π·Π΄ΠΎΡΠΎΠ²ΡΡ
Π»ΡΠ΄Π΅ΠΉ). ΠΡΡΠ²Π»Π΅Π½Ρ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ Π² ΡΡΡΡΠΊΡΡΡΠ΅ ΠΌΠ΅ΠΌΠ±ΡΠ°Π½ ΡΡΠΈΡΡΠΎΡΠΈΡΠΎΠ², ΠΊΠΎΡΠΎΡΡΠ΅ ΠΏΡΠΈΠ²ΠΎΠ΄ΡΡ ΠΊ Π½Π°ΡΡΡΠ΅Π½ΠΈΡ ΡΡΠ½ΠΊΡΠΈΠΉ Π±Π΅Π»ΠΊΠΎΠ² ΡΠΈΡΠΎΡΠΊΠ΅Π»Π΅ΡΠ°. Π Π΅Π·ΡΠ»ΡΡΠ°ΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΠΎΠ±ΡΡΡΠ½ΡΡΡ ΠΏΡΠΈΡΠΈΠ½Ρ Π²ΠΎΠ·Π½ΠΈΠΊΠ½ΠΎΠ²Π΅Π½ΠΈΡ ΡΡΠΈΡ
ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΠΉ
Roadmap on holography
From its inception holography has proven an extremely productive and attractive area of research. While specific technical applications give rise to 'hot topics', and three-dimensional (3D) visualisation comes in and out of fashion, the core principals involved continue to lead to exciting innovations in a wide range of areas. We humbly submit that it is impossible, in any journal document of this type, to fully reflect current and potential activity; however, our valiant contributors have produced a series of documents that go no small way to neatly capture progress across a wide range of core activities. As editors we have attempted to spread our net wide in order to illustrate the breadth of international activity. In relation to this we believe we have been at least partially successful.This work was supported by Ministerio de EconomΓa, Industria y Competitividad (Spain) under projects FIS2017-82919-R (MINECO/AEI/FEDER, UE) and FIS2015-66570-P (MINECO/FEDER), and by Generalitat Valenciana (Spain) under project PROMETEO II/2015/015
Roadmap on holography
From its inception holography has proven an extremely productive and attractive area of research. While specific technical applications give rise to 'hot topics', and three-dimensional (3D) visualisation comes in and out of fashion, the core principals involved continue to lead to exciting innovations in a wide range of areas. We humbly submit that it is impossible, in any journal document of this type, to fully reflect current and potential activity; however, our valiant contributors have produced a series of documents that go no small way to neatly capture progress across a wide range of core activities. As editors we have attempted to spread our net wide in order to illustrate the breadth of international activity. In relation to this we believe we have been at least partially successful
Biochemical composition of urine in rats with developed Guerinβs carcinoma and administration of cisplatin
The kidneys are very sensitive to the action not only of exogenous chemicals but also the action of compounds of endogenous origin, produced by changes in the normal metabolic processes and the development of various pathologies. Thus, tumour development has a significant impact on overall homeostasis of the body. Research into the condition of the kidneys subject to growth of tumours when cisplatin is administered is a major issue in both medical and biochemical aspects. We investigated the renal function, electrolyte composition of the blood and urinary excretion of electrolytes and individual plasma osmolarity in models of tumour growth in rats subject to introduction of cisplatin. We found that development of Guerinβs carcinoma T8 and the administration of cisplatin causes kidney damage in rats. This leads to an increase in the relative weight of the kidneys, proteinuria, and changes in activity of Ξ³-glutamyl-transferase and lactate dehydrogenase in the kidney homogenate and urine, lower relative reabsorption and glomerular filtration. The development of Guerinβs carcinoma and administration of cisplatin in the blood and urine of rats led to a decrease in diuresis per minute by 20β60%, creatinine clearance by 50β70% and reduction in the relative water reabsorption in the renal tubules to 26% compared with the control. The administration of cisplatin led to a threefold increase in the concentration of protein, twofold increase in the concentration of albumin and sevenfold increase in the concentration of glucose in the ratsβurine. In the case of rats with lesions and renal diseases (including different types of tumours) a reduction in the output of urine per minute, creatinine clearance and water reabsorption in the renal tubules was observed, indicating significant damage to the concentration and filtration functions of the kidneys. Tumour growth led to the development of hypokalemia, hyponatremia and hypochloridemia, which are major and early signs of acute renal failure. The introduction of cisplatin led to damage to the kidneys and partly normalized these indicators, as evidenced by biochemical and morphological studies. Our study shows that there is a pressing need for use of drugs which protect the kidneys when cisplatin is administered